It has shown higher average weight loss percentages, with some patients losing up to 20% of their body weight at higher doses over a longer period
The Clinical Data: Everything Published So Far Phase 1 First-in-Human (Oral Formulation) Published: The Lancet, June 2025 Participants: 144 adults with overweight or obesity (BMI 25.039.9), no diabetes Duration: Up to 12 weeks Dosing: Once-daily oral amycretin, up to 2 50 mg Results: - 50 mg dose: 10.4% mean body weight change - 2 50 mg dose: 13.1% mean body weight change - Placebo: 1.2% 13% weight loss in 12 weeks
Supplements While oral L-carnitine supplements are readily available, their effectiveness can be limited due to low absorption rates
ORCID iDs: Chii-Wann Lin Shang-Po Wang References 1.ebron U, Mayer JA, Lu C, Daigeler A, Prahm C, Kolbenschlag J
Supports Fluid Balance: Aids in maintaining optimal hydration levels
more than 60 countries and regions, as well as offer customized energy optimization and sustainable cold chain solutions